Tag: Provident Healthcare Partners
Infusion services: Analysts see ‘shift in thought process’
August 23, 2024Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Ambulatory infusion suites have become the fastest-growing segment in the home infusion and specialty pharmacy market, say analysts.
While Provident estimates that 55% of infusion services are conducted in the hospital, 30% in the home, 10% in office-based settings like physician offices and 5% in AICs, the latter is growing in the double digits, it says.
“Both from a margin perspective and the number of patients the staff can handle, I think you are...
M&A analysts: ‘Focus on acquiring solid companies’
February 10, 2023Theresa Flaherty, Managing Editor
YARMOUTH, Maine – Industry analysts see steady deal-making in 2023, with a variety of companies making buys in both typically hot markets like respiratory and newly hot markets like repairs, but with more of a focus on due diligence.
“I think the interest is at both the national level, as well as the larger regionals, aggressively pursuing acquisitions,” said Pat Clifford, managing director, home medical equipment, for The Braff Group. “There is acquisition appetite...
Mergers & Acquisitions: Have transparent, upfront conversations
December 6, 2022Kevin Palamara
Q. What steps should I be taking to most effectively position my company to go through an M&A process?
A. Foremost, ensuring organizational alignment before approaching the market is paramount in setting yourself up for a successful process. It’s critical to achieve stakeholder agreement in terms of transaction goals, deal structure (e.g., majority vs. minority investment, strategic vs. private equity partner), timeline and valuation expectations to minimize the likelihood of...
Mergers & Acquisitions: Assess benefits, drawbacks
November 9, 2022Kevin Palamara
Q. Is pursuing an M&A transaction process the right decision for my organization?
A. Typical motivations to begin an M&A process are to generate owner liquidity, mitigate personal financial risk, raise capital to fund growth initiatives (e.g., acquisitions, new service offerings, etc.), gain strategic resources and infrastructure capabilities, or take a step back from the business to retire or explore other ventures.
M&A processes can also create opportunities to partner with like-minded...
Mergers & Acquisitions: Assess interest rates, recessionary fears
October 12, 2022Kevin Palamara
Q. How will rising interest rates affect the M&A market for HME businesses?
A. As the Federal Reserve has raised interest rates to help combat inflation, private equity sponsors who utilize debt to finance a portion of their acquisitions have been faced with higher borrowing costs. Debt providers typically price loans off a certain benchmark rate (e.g., LIBOR, federal funds rate, etc.), and as those benchmark rates have risen, the cost of debt to finance acquisitions has increased alongside...
Mergers & Acquisitions: Understand the current landscape
September 7, 2022Kevin Palamara
Q. How has the M&A environment for HME providers shifted over time?
A. Following the introduction of competitive bidding in the early 2010s, M&A activity in the HME sector grounded to a halt, as reimbursement was cut drastically. However, as the marginal impact of each subsequent round of competitive bidding lessened and the reimbursement environment stabilized, investors demonstrated a renewed interest in HME providers, driven by market tailwinds that have positioned the sector for growth....
Home infusion: Interest still high, inventory still low
March 4, 2022Theresa Flaherty, Managing Editor
YARMOUTH, Maine – A handful of recently announced deals underscores the continued appetite for home infusion companies propelled by the COVID-19 pandemic, say M&A analysts.
Option Care Health recently announced it acquired Wasatch Infusion and entered into an agreement to acquire Specialty Pharmacy Nursing Network.
“Option Care has been doing deals for 20 years and I don’t think that’s going to stop – they continue to fill out their geographic...
BioScrip gets serious about home infusion
June 21, 2013Theresa Flaherty, Managing Editor
ELMSFORD, N.Y. - BioScrip announced last week that it plans to acquire Cincinnati, Ohio-based CarePoint Partners for $223 million.
Under the deal, BioScrip will gain approximately 20,500 patients, bringing its total to 100,000, mostly in the eastern half of the country.
“With the market as robust as it is right now, they are wise to do an opportunistic transaction,” said Jonathan Sadock, managing partner with Paragon Ventures. “It's a nice price and they have been growing...